Karkkainen M J, Petrova T V
Molecular Cancer Biology Laboratory, and the Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, 00014 Helsinki, Finland.
Oncogene. 2000 Nov 20;19(49):5598-605. doi: 10.1038/sj.onc.1203855.
VEGFR-1 (Flt-1), VEGFR-2 (KDR) and VEGFR-3 (Flt4) are endothelial specific receptor tyrosine kinases, regulated by members of the vascular endothelial growth factor family. VEGFRs are indispensable for embryonic vascular development, and are involved in the regulation of many aspects of physiological and pathological angiogenesis. VEGF-C and VEGF-D, as ligands for VEGFR-3 are also capable of stimulating lymphangiogenesis and at least VEGF-C can enhance lymphatic metastasis. Recent studies have shown that missense mutations within the VEGFR-3 tyrosine kinase domain are associated with human hereditary lymphedema, suggesting an important role for this receptor in the development of the lymphatic vasculature.
血管内皮生长因子受体-1(Flt-1)、血管内皮生长因子受体-2(KDR)和血管内皮生长因子受体-3(Flt4)是内皮特异性受体酪氨酸激酶,受血管内皮生长因子家族成员调控。血管内皮生长因子受体对胚胎血管发育不可或缺,并参与生理和病理血管生成多个方面的调节。作为血管内皮生长因子受体-3的配体,血管内皮生长因子-C和血管内皮生长因子-D也能够刺激淋巴管生成,并且至少血管内皮生长因子-C可增强淋巴转移。最近的研究表明,血管内皮生长因子受体-3酪氨酸激酶结构域内的错义突变与人类遗传性淋巴水肿相关,提示该受体在淋巴管系统发育中起重要作用。